The abstract is read at the publisher; the summary is JClub's.
Rapid genome sequencing in non-ICU hospitalized children achieved a 39% diagnostic rate (32 of 83) and most diagnostic cases led to care changes within 30 days.
- Why it matters: Evidence for rapid genome sequencing outside pediatric ICU settings is limited, leaving uncertainty about whether it meaningfully informs non-critically ill inpatient management.
- What they did: From 2019–2023, the study analyzed rapid genome sequencing results for 83 non-ICU hospitalized children and used chart review to assess management changes during the first 30 days after testing.
- The result: In non-ICU patients with diagnostic results, 81% had a management change within 30 days, and 56% (18 of 32) received disease-targeted interventions, most often metabolic (61%, 11 of 18) or epilepsy (22%, 4 of 18).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.